RARA and acute promyelocytic leukemia: Tretinoin, a derivative of Vitamin A, can function via targeting the retinoic acid receptor alpha (RARα)-mediated signals to alter the cell apoptosis [17], and has been used as a medication to treat acute promyelocytic leukemia (APL) for decades [18].